Shanghai Labway Clinical Laboratory Co (SZSE:301060) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Labway Clinical Laboratory Co Other Net Income (Loss)?

Shanghai Labway Clinical Laboratory Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.

Shanghai Labway Clinical Laboratory Co's quarterly Other Net Income (Loss) declined from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥0 Mil) but then increased from Dec. 2024 (¥0 Mil) to Mar. 2025 (¥0 Mil).

Shanghai Labway Clinical Laboratory Co Other Net Income (Loss) Historical Data

The historical data trend for Shanghai Labway Clinical Laboratory Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Labway Clinical Laboratory Co Other Net Income (Loss) Chart

Shanghai Labway Clinical Laboratory Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Shanghai Labway Clinical Laboratory Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Labway Clinical Laboratory Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shanghai Labway Clinical Laboratory Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Shanghai Labway Clinical Laboratory Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Labway Clinical Laboratory Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shanghai Labway Clinical Laboratory Co Ltd (SZSE:301060) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 268, Linxin Road, Floor 6, 7, 8, 9 of Building 1, Changning District, Shanghai, CHN, 200335

Website

https://www.labway.cn

Shanghai Labway Clinical Laboratory Co Ltd provides comprehensive health management solutions relying on medical laboratory and pathological diagnosis services. It offers genetic testing, clinical microbiology testing, blood and pathology testing, cytopathological diagnosis, and other services.

Executives

Sun Lin Jie

Director

Shanghai Labway Clinical Laboratory Co Headlines

No Headlines